Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin condition affected only the facial hair of a 46-year-old man.

Wax injection did not stop hair loss and caused changes to the skull.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

New ginseng compounds may help treat degenerative diseases.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Early diagnosis and treatment of alopecia in children are crucial for managing physical and psychological impacts.

A child with rough nails also had hair loss and allergies.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Different types of hair loss require specific treatments, and new treatments are being developed.

Ayurvedic treatment led to significant hair regrowth in an 11-year-old with alopecia areata.

Cyclosporine may cause hair loss, so patients need monitoring.

Two sisters had rare, widespread cysts and complete hair loss, suggesting a genetic link.

Ozonated oil helped heal a wound but caused hair loss.

Early-stage Alopecia Areata was effectively treated in less than six months.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.